HealthStream, Inc. (HSTM) vs Jade Biosciences, Inc. (JBIO)
A side-by-side comparison of HealthStream, Inc. and Jade Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
HSTM
HealthStream, Inc.
$31.32HealthcareDelayed quote: Oct 6, 2026, 1:05 PM EDT
JBIO
Jade Biosciences, Inc.
$13.32HealthcareDelayed quote: Oct 6, 2026, 1:05 PM EDT
Total return — HSTM vs JBIO
growth of $100 · dividends reinvested · last 5yHSTM +17.1% (+3.2%/yr)JBIO -97.8% (-53.5%/yr)HSTM compounded faster over this window
Log scale — wide-divergence pair
HSTM JBIO
HSTM vs JBIO: by the numbers
- •HSTM is the larger company ($915M vs $811M market cap).
- •HSTM is profitable (6.60% net margin) while JBIO runs a net loss (0.00%).
- •HSTM pays a dividend (0.43% yield), while JBIO is a former payer with no current dividend run rate.
Metrics side by side
Valuation
| Metric | HSTM | JBIO |
|---|---|---|
| P/E ratio | 43.78 | N/A |
| Forward P/E | 42.43 | N/A |
| PEG ratio | 6.49 | N/A |
| P/S ratio | 2.85 | N/A |
| P/B ratio | 2.57 | 1.84 |
| EV / EBITDA | 12.55 | N/A |
| FCF yield | 5.34% | N/A |
Profitability
| Metric | HSTM | JBIO |
|---|---|---|
| Gross margin | 65.08% | 0.00% |
| Operating margin | 8.04% | 0.00% |
| Net margin | 6.60% | 0.00% |
| ROE | 5.94% | -34.83% |
| ROIC | 4.96% | -37.39% |
Dividends
| Metric | HSTM | JBIO |
|---|---|---|
| Dividend yield | 0.43% | N/A |
| Payout ratio | 19.01% | N/A |
Growth (annualized)
| Metric | HSTM | JBIO |
|---|---|---|
| Revenue CAGR (5Y) | 5.05% | N/A |
| EPS CAGR (5Y) | 6.75% | N/A |
| FCF CAGR (5Y) | 2.33% | N/A |
| Total return CAGR (5Y) | 2.34% | -52.65% |
Frequently asked
- Does HSTM or JBIO pay a bigger dividend?
- HSTM pays a dividend (0.43% yield), while JBIO is a former payer with no current dividend run rate.
- Is HSTM or JBIO more profitable?
- HSTM runs the higher net margin — HSTM at 6.60% versus JBIO at 0.00%.
- How have HSTM and JBIO total returns compared?
- Over the past 5 years, HSTM delivered 2.34% and JBIO delivered -52.65% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
HealthStream P/E ratioHealthStream dividend yieldHealthStream ROEJade Biosciences ROEHealthStream operating marginJade Biosciences operating marginHealthStream revenue growthJade Biosciences revenue growthHealthStream free cash flowJade Biosciences free cash flow
HealthStream & Jade Biosciences appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.